BRISTOL-MYERS SQUIBB COMPANY v. APOTEX, INC. et al, No. 3:
2010cv05810 - Document 142 (D.N.J. 2013) case opinion from the District of
New Jersey ...
Pan.Mult.Lit. Dec. 21,. 2004((No. MDL 1648). Page 84. In re Sorbates Direct ..... v.
Bristol-Myers Squibb Co, et al, No. 01-CV. 11401, MDL 1413 (available at.
(95-2084); Bristol-Myers Squibb Co.; Medical Engineering Corporation ... E. Pitts,
Jr. (argued), Sidley & Austin, New York City, for Bristol-Myers Squibb ... those
actions to Chief Judge Pointer of the Northern District of Alabama. .... A.H. Robins
Co. v. ... In re Pan Am Corp., 16 F.3d 513, 515 (2d Cir.1994) (“In re Pan Am Corp.
Oct 13, 2010 ... Indeed, recently, it was demonstrated that the presence of E255K/V, Y253H, or
F359C/V ... Bristol-Myers Squibb did not influence the content of the article, nor
did the authors receive ... Baccarani M, Cortes J, Pane F, et al. ... Sprycel [
package insert] Princeton, NJ: Bristol-Myers Squibb Company; 2009. 33.
Aug 8, 2013 ... A US and Canadian Intergroup trial of dasatinib vs imatinib reported similar
results. ... of the patients in whom previous TKI therapy failed, based on a
company-sponsored, ... Pavlu et al updated the Hammersmith results for patients
..... as consultant and advisor of Novartis, Bristol-Myers Squibb, and Ariad; ...
Dec 1, 2014 ... Ipilimumab (Yervoy®, Bristol-Myers Squibb) and nivolumab (OPDIVO, ....
However, initially its function was not fully understood (Brunet et al., 1987). ....
Monoclonal antibodies that directly activate CD137 can co-stimulate and ..... 10.9
vs. 5.7%), and progression-free survival (PFS) (with medians of 2.76 vs.
Representation of Bristol-Myers Squibb in patent litigation in the District of New
Jersey ... Bristol-Myers Squibb Company v. Dr. Reddy's Laboratories Ltd., et al.
Development lab at Bristol-Myers Squibb) through the 2-year measurement, after
which they .... SHAH et al. BLOOD, 10 .... Furthermore, regardless of imatinib
resistance (resistance vs re- sistance or ..... Princeton, NJ: Bristol-Myers Squibb
Company; 2013. 9. ... Baccarani M, Cortes J, Pane F, et al; European.
Apr 20, 2015 ... Consulting or Advisory Role: Bristol-Myers Squibb, ARIAD Pharmaceuticals ....
Yang JC,; Hirsh V,; Schuler M,; et al. ... Kwak EL,; Bang YJ,; Camidge DR,; et al. ...
(1999) B7-H1, a third member of the B7 family, co-stimulates T-cell ..... A Patient-
Derived, Pan-Cancer EMT Signature Identifies Global Molecular ...
Jan 10, 2015 ... Hongming Pan, Sir Run Run Shaw. Hospital ... e-mail: email@example.com.
..... Cainap et al .... the linifanib arm (P .05) was increased ALT (4.8% v 2.2%). ....
Novartis; Pei-Jer Chen, Bristol-Myers Squibb, Roche, Janssen.